Filters: press-releases




20160128 EGA Regulatory and Scientific Affairs Conferenc

Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition

26 October 2022

Read More

Rapid policy action needed to protect patient access to essential medicines as inflation bites

12 October 2022

Read More

EU pharmaceutical legislation reform critical to sustain biosimilar medicines competition for the future

6 October 2022

Read More

Updated Guide to empower nurses managing patients on biological therapies

3 October 2022

Read More

Open Medicines for Europe letter ahead of the Energy Council – 27 September 2022

27 September 2022

Read More

EMA/HMA share definitive EU-wide position on biosimilar medicines interchangeability

19 September 2022

Read More

Medicines for Europe is part of the REMEDi4ALL consortium! An EU-funded research initiative aiming at driving forward the repurposing of medicines in Europe

2 September 2022

REMEDi4ALL launched yesterday with the aim of making a major […]

Read more

Medicines for Europe warns strongly against energy rationing for medicines production

20 July 2022

Read More

The Supplementary Protection Certificate (SPC) manufacturing waiver becomes operational!

1 July 2022

Read More

The off-patent medicines industry is a vital part of the solution for healthcare resilience

30 June 2022

Read More

Subscribe to our newsletter